Post-therapy surveillance and after-care in ovarian cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 114, Issue 2, 2004, Pages 228-233

  Von Georgi, Richard ^a   Schubert, Kai ^a   Grant, Phillip ^a   Münstedt, Karsten ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

After care; Follow up; Ovarian cancer

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN;

ADULT; AFTERCARE; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER THERAPY; DATA ANALYSIS; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SURVIVAL; TECHNIQUE; TIME; TUMOR;

EID: 2442434499     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2003.10.029     Document Type: Article

References (23)

1. del Turco R., Palli D., Cariddi A., Ciatto S., Pacini P., Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. J. Am. Med. Assoc. 271:1994;1593-1597
2. Tumorzentrum M. Empfehlungen zur Diagnostik, Therapie und Nachsorge - Maligne Ovarialtumoren. Zuckschwerdt: München; 2001.
3. Barnhill D., O'Connor D., Farley J., Teneriello M., Armstrong D., Park R. Clinical surveillance of gynecologic cancer patients. Gynecol. Oncol. 46:1992;275-280
4. Kurz L., Vawra N., Sevelda P. Nachsorge und palliative Therapiemaßnahmen beim Ovarialkarzinom. Wien Med. Wschr. 146:1996;34-37
5. Seewaldt VL, Goff BA, Greer BE, Niloff JM. Post-therapy surveillance in patients with epithelial ovarian cancer. In: Gershenson DM, McGuire WP, editors. Ovarian cancer - controversies in management. New York: Churchil Livingstone; 1998. p. 309-23.
6. Chang W.C., Hung Y.C., Kao C.H., Yen R.F., Shen Y.Y., Lin C.C. Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumour markers. Neoplasma. 49:2002;329-333
7. Markman M. Follow-up of the asymptomatic patient with ovarian cancer. Gynecol. Oncol. 55(3 Pt 2):1994;S134-137
8. National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol 1994;55:S4-14.
9. Högberg T., Kagedal B. Long-term follow-up of ovarian cancer with monthly determinations of serum CA 125. Gynecol. Oncol. 46:1992;191-198
10. Benson K., Hartz A.J. A comparison of observational studies and randomized, controlled trials. N. Engl. J. Med. 342:2000;1878-1886
11. Dauplat J., Hacker N.F., Nieberg R.K., Berek J.S., Rose T.P., Sagae S. Distant metastasis in epithelial ovarian cancer. Cancer. 60:1987;1561-1566
12. von Georgi R., Schubert K., Franke F.E., Münstedt K. Auswirkungen soziomedizinischer Risikofaktoren auf den Verlauf des Ovarialkarzinoms. Dtsch. Med. Wschr. 127:2002;2001-2005
13. Müller J.M., Tübergen D., Zieren U. Nachsorge beim kolorektalen Karzinom. Zentralbl. Chir. 119:1994;65-74
14. Baufeld K., Kullmer U., Kalder M., Vahrson H., Münstedt K. Zur Nachsorge des Endometriumkarzinoms. Geburtsh Frauenheilk. 60:2000;423-428
15. Schumacher T., Schmitz S., Diehl V. Prognoserelevanz der onkologischen Nachsorge. Versicherungsmedizin. 47:1995;166-170
16. Shadbolt B., Barresi J., Craftz P. Self-rated health as a predictor of survival among patients with advanced cancer. J. Clin. Oncol. 20:2002;2514-2519
17. Brundage M.D., Davidson J.R., Mackillap W.J. Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J. Clin. Oncol. 15:1997;330-340
18. Faul C., Gerszten K., Edwards R., Land S., D'Angelo G., Kelley J., Price F. A phase I/II study of hypofractionated whole abdominal radiation therapy in patients with chemoresistant ovarian carcinoma: Karnofsky score determines treatment outcome. Int. J. Radiat. Oncol. Biol. Phys. 47:2000;749-754
19. Jänicke F., Holscher M., Kuhn W., von Hugo R., Pache L., Sievert J.R., Graeff H. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer. 70:1992;2129-2136
20. Eisenkop S.M., Friedman R.L., Spirtos N.M. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer. 88:2000;144-153
21. Buller R.E., Skilling J.S., Sood A.K., Plaxe S., Baergen R.N., Lager D.J. Field cancerization: why late "recurrent" ovarian cancer is not recurrent. Am. J. Obstet. Gynecol. 178:1998;641-649
22. Stähle A., Emons G., Kühnle H. Nachsorge und Hormonsubstitution nach Ovarialkarzinom. Onkologe. 8:2002;1230-1235
23. Münstedt K., von Georgi R., Zygmunt M., Misselwitz B., Stillger B., Künzel W. Shortcomings and deficits in surgical treatment of gynecological cancers: a German problem only. Gynecol. Oncol. 86:2002;337-343